Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion of Valproate to Lamotrigine in Epilepsy
NCT00043914Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2002
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lamotrigine in epilepsy, sponsored by GSK. Started Jan 2002; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00043914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043914.